Jazz Pharmaceuticals plc
JAZZ· Nasdaq
Released May 5, 2020, after the close
10-Q filed May 5, 2020, 35 days after period end · 0001232524-20-000034
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $534.73M | $508.19M | $444.61M | $376.05M |
| Net Income | -$157.83M | $85.20M | $45.99M | $86.51M |
| EPS Diluted |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| -$2.82 |
| $1.47 |
| $0.75 |
| $1.41 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.